Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci

被引:16
|
作者
da Silva, Natal Santos [1 ,2 ]
Muniz, Vitor Dantas [3 ]
Estofolete, Cassia Fernanda [3 ,4 ]
Campos Furtado, Guilherme Henrique [5 ]
Rubio, Fernando Gongora [3 ]
机构
[1] Med Coll Sao Jose do Rio Preto, Postgrad Dept, Sao Paulo, Brazil
[2] Union Coll Great Lakes, Coll Med, Dept Med Sci, Sao Paulo, Brazil
[3] Hosp Base, Dept Infect & Parasit Dis, Sao Paulo, Brazil
[4] Med Coll Sao Jose do Rio Preto, Virol Lab, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Dept Infect Dis, Hosp Epidemiol Comm, Sao Paulo, Brazil
关键词
Cohort study; Sepsis; Antibiotic; Resistance profile; EPIDEMIOLOGY; ACQUISITION; INFECTIONS; MORTALITY; OUTCOMES;
D O I
10.1016/j.ajic.2013.11.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: This study aimed to evaluate a different methodology for addressing the evolution of nosocomial bacteremia by vancomycin-resistant enterococci (VRE) in a hospital setting. Methods: In this retrospective cohort study, data were collected from the date of first registration up to December 2008 from the electronic medical records of patients with VRE bacteremia in a school hospital. Results: Thirty cases of VRE bacteremia and 274 cases of vancomycin-susceptible enterococci (VSE) bacteremia were identified. The average age of the patients was 56 years. The rates of Enterococcus faecium and Enterococcus faecalis in the hospital's intensive care unit (ICU) and wards showed no statistically significant differences. The risk of acquiring VRE bacteremia was at least 3-fold higher in the ICU than in the wards. The risk of death was 2.73-fold higher in patients with VRE bacteremia compared with those with VSE bacteremia. Only one temporal cluster statistically significant of VRE bacteremia was found in the study period. Conclusions: The identification of temporal clusters can be an important tool to optimize health actions and thereby reduce the burden of operating costs. Copyright (C) 2014 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:389 / 392
页数:4
相关论文
共 50 条
  • [41] To Determine The Risk Factors Associated With Mortality In Patients With Vancomycin Resistant Enterococci Bacteremia
    Mathew, N. E.
    Benavidez, J.
    Aslam, W.
    MunozMaldonaldo, Y.
    Liu, Y.
    Fader, R.
    Brito, V.
    Ghamande, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium Bacteremia in cancer patients
    Ghanem, G.
    Hachem, R.
    Jiang, Y.
    Chemaly, R. F.
    Raad, I.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (09): : 1054 - 1059
  • [43] Vancomycin-resistant enterococci in Austria
    Allerberger, F
    LassFlorl, C
    Dierich, MP
    Hirschl, AM
    Presterl, E
    Haas, G
    Klare, I
    Witte, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (09) : 312 - 320
  • [44] Vancomycin-resistant enterococci: A review
    Joshi, N
    Milfred, D
    Caputo, G
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (09) : 528 - 535
  • [45] Topic: Vancomycin-resistant enterococci
    Richard B. Roberts
    Journal of Urban Health, 1998, 75 : 512 - 513
  • [46] Resistance in Vancomycin-Resistant Enterococci
    Miller, William R.
    Murray, Barbara E.
    Rice, Louis B.
    Arias, Cesar A.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2020, 34 (04) : 751 - +
  • [47] Commentary: Vancomycin-resistant enterococci
    Welton, L
    Zervos, MJ
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (09) : 535 - 537
  • [48] The epidemiology of vancomycin-resistant enterococci
    Goossens, H
    CURRENT OPINION IN INFECTIOUS DISEASES, 1999, 12 (06) : 537 - 541
  • [49] Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci
    Sakka, V.
    Tsiodras, S.
    Galani, L.
    Antoniadou, A.
    Souli, M.
    Galani, I.
    Pantelaki, M.
    Siafakas, N.
    Zerva, L.
    Giamarellou, H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (01) : 14 - 21
  • [50] Vancomycin-resistant enterococci: Risk related to the use of intravenous vancomycin.
    Fuller, RE
    Colvin, LG
    Meredith, FT
    Wilkinson, WE
    Harrell, LJ
    Sexton, DJ
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 47 - 47